🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Texas

464 posts
NUU N10 Plus launches in the United States with Android 16 and a $169.99 price tag
Read More

NUU N10 Plus packs Android 16 and a 50MP camera for $169.99, but is 4G enough in 2026?

NUU has launched the N10 Plus, a $169.99 unlocked Android 16 smartphone featuring a 6.6-inch display, 50-megapixel main camera, NFC connectivity and a 5,000mAh battery. The device targets budget-conscious American consumers, but its reliance on 4G LTE creates a competitive challenge as affordable 5G alternatives become increasingly accessible.
Bovita Health launches colostrum and metabolic fiber supplement targeting gut health
Read More

Bovita Health combines colostrum, fiber and Akkermansia. Can its new formula compete in metabolic wellness?

Bovita Health has introduced Colostrum + Metabolic Fiber, combining bovine colostrum, dietary fiber and Akkermansia in a daily supplement positioned around appetite and metabolic wellness. The product enters a growing market for gut-focused formulations, where scientific substantiation and repeat purchases are important competitive factors.
BP’s potential acquisition of Devon Energy’s Eagle Ford shale operations could significantly expand BPX Energy production while testing the company’s debt-reduction and capital-allocation strategy. Representative image.
Read More

Why BP is looking at Devon Energy’s Eagle Ford assets while trying to cut debt

BP p.l.c. is reportedly evaluating Devon Energy Corporation’s South Texas shale operations, potentially putting a multi-billion-dollar acquisition alongside an aggressive debt-reduction and divestment programme. The strategic logic is unusually clear because the assets could move BPX Energy close to its 2030 production target, but valuation and financing discipline may determine whether that logic translates into a transaction.
Read More

SB Energy heads for IPO with $439bn backlog and Nvidia committing $3bn

SoftBank-backed SB Energy has filed for a Nasdaq IPO with about $439 billion of contracted backlog and 8.8 GW of data-centre capacity contracted or under construction. Yet none of its data centres is operating today, first-half revenue was only $138.7 million and the company reported a $3.21 billion net loss distorted heavily by OpenAI warrant revaluation. The listing will test how much public investors are prepared to pay today for AI infrastructure cash flows stretching decades into the future.
Read More

Bamboo Insurance has $879m of managed premium, but its IPO comes with a $548m debt question

CVC-backed Bamboo Insurance Services has filed for a New York Stock Exchange listing after managed premium approached $879 million and first-half revenue grew 40%. The capital-light insurance model is producing strong adjusted margins, but a $548 million term loan, declining GAAP profit and catastrophe exposure will make the eventual IPO price critical.